VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 122 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $36,192,000 | -16.3% | 2,175,000 | -43.7% | 0.39% | -10.9% |
| Q2 2016 | $43,246,000 | +31.7% | 3,864,717 | -1.6% | 0.44% | +81.1% |
| Q1 2016 | $32,830,000 | -10.6% | 3,927,000 | -0.5% | 0.24% | +10.5% |
| Q4 2015 | $36,742,000 | -17.5% | 3,946,500 | 0.0% | 0.22% | -4.8% |
| Q3 2015 | $44,517,000 | -11.1% | 3,946,500 | 0.0% | 0.23% | 0.0% |
| Q2 2015 | $50,081,000 | +36.3% | 3,946,500 | -0.1% | 0.23% | +23.5% |
| Q1 2015 | $36,735,000 | -29.2% | 3,950,000 | +9.0% | 0.19% | -30.2% |
| Q4 2014 | $51,910,000 | +53.9% | 3,625,000 | +11.5% | 0.27% | +91.4% |
| Q3 2014 | $33,735,000 | -34.8% | 3,250,000 | +1.6% | 0.14% | -37.5% |
| Q2 2014 | $51,776,000 | +128.8% | 3,200,000 | +129.8% | 0.22% | +101.8% |
| Q1 2014 | $22,628,000 | – | 1,392,500 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |